Opportunity Information: Apply for CDC RFA DP15 1515
Apply for CDC RFA DP15 1515
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Preventing Heart Attacks and Strokes in High Need Areas" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Apr 23, 2015 and posted on Apr 23, 2015.
- Applicants must submit their applications by Jun 30, 2015 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,150,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $3,150,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: State governments.
- This is a Type 2 continuation cooperative agreement, which will provide funds for one additional budget year (from September 30, 2015 to September 29, 2016) beyond the previously approved project period (from September 30, 2010 to September 29, 2015) for DP101013 Mississippi Delta Health Collaborative. As such, this award will be a continuation of funds intended only for the grantee previously awarded under DP10 1013. Accordingly, financial assistance from this FOA will be provided only to the Mississippi Department of Health / Mississippi Delta Health Collaborative (MDHC). No other applications will be solicited, or will be reviewed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Preventing Heart Attacks and Strokes in High Need Areas (CDC RFA DP15-1515) is a one-year continuation funding opportunity from the Centers for Disease Control and Prevention designed to help the Mississippi Delta Health Collaborative (MDHC) finish and strengthen ongoing work to prevent heart disease, stroke, and related chronic conditions. The main idea is practical and time-sensitive: MDHC already has established activities underway in Mississippi's Delta Region, and this additional year of support is intended to complete work that might otherwise stall or remain unfinished due to limited time and funding at the end of the original project period. Rather than launching a brand-new initiative, the grant extends momentum, reinforces partnerships, and ensures that proven interventions continue reaching high-need communities.
The program is structured as a cooperative agreement, meaning CDC is expected to remain actively involved through technical assistance and collaboration rather than simply issuing funds with minimal engagement. The single award totals $3,150,000, with both the award ceiling and floor set at the same amount, and there is no cost sharing or matching requirement. The funding falls under CFDA 93.283 (CDC Investigations and Technical Assistance) and is categorized as discretionary health funding. The posting date was April 23, 2015, with applications due June 30, 2015, and an archive date of July 30, 2015.
A key feature of this announcement is that it is not a competitive opportunity open to multiple applicants. It is a Type 2 continuation award that provides one additional budget year, covering September 30, 2015 through September 29, 2016, beyond the previously approved project period that ran from September 30, 2010 through September 29, 2015. Eligibility is limited to the original grantee: the Mississippi Department of Health / Mississippi Delta Health Collaborative. No other applications were solicited or reviewed, reflecting that the purpose is specifically to continue and complete an existing CDC-supported effort rather than to select a new organization or expand to other states.
Programmatically, the work is centered in Mississippi's 18-county Delta Region and focuses on priority populations experiencing disproportionate cardiovascular risk and barriers to care. The interventions are organized around the "ABCS" framework, which targets the most widely recognized, high-impact levers for preventing heart attacks and strokes: Aspirin therapy when appropriate, Blood pressure control, Cholesterol management, Smoking cessation, and Smoke-free ordinances. This mix is intentional because it connects clinical care improvements (such as better hypertension management and appropriate medication use) with community-level strategies (such as tobacco cessation supports and smoke-free policies) that reduce population risk over time.
The announcement emphasizes that MDHC will continue intensifying collaboration across a broad local and state network. This includes coordination among the Mississippi Department of Health and its chronic disease programs (heart disease and stroke prevention, diabetes, tobacco control, nutrition, and physical activity), local health departments, and community health care providers such as Federally Qualified Health Centers. Community partners are also central to the approach, and CDC remains engaged as a technical and strategic collaborator. The goal is to align clinical systems, public health infrastructure, and community supports so that preventive services and risk reduction strategies are easier to access, more consistent, and better targeted to local needs.
To guide deliverables and accountability, MDHC is expected to complete or address seven major recipient activity areas. These include: (1) program infrastructure, staffing, management, and support to keep operations stable and effective; (2) fiscal management to ensure funds are properly tracked and used; (3) leadership team functions and the development and maintenance of partnerships to keep stakeholders coordinated; (4) implementation of clinical interventions that improve how care teams prevent and manage cardiovascular risk; (5) implementation of community-based educational, policy, and systems interventions that shape healthier environments and behaviors; (6) program evaluation and surveillance to measure progress, monitor outcomes, and inform improvements; and (7) collaboration with other chronic disease programs to integrate efforts and avoid siloed work, since cardiovascular outcomes are closely linked with diabetes, tobacco use, diet, and physical inactivity.
Overall, this grant opportunity is best understood as a targeted bridge year of funding meant to protect and complete an established, region-wide cardiovascular prevention initiative in one of Mississippi's highest-need areas. It combines health system change, community-level prevention, strong cross-sector partnerships, and ongoing measurement to reduce heart attacks and strokes, with a clear focus on sustaining and finishing concrete activities already in motion. For additional information or access issues related to the full announcement, the listed CDC contact is Refilwe Moeti at REM7@cdc.gov.
Frequently Asked Questions (FAQs)
What is the "Preventing Heart Attacks and Strokes in High Need Areas (CDC RFA DP15-1515)" opportunity?
It is a one-year continuation funding opportunity from the Centers for Disease Control and Prevention (CDC) intended to help the Mississippi Delta Health Collaborative (MDHC) finish and strengthen ongoing work to prevent heart disease, stroke, and related chronic conditions in Mississippi's Delta Region.
Is this a new program or an extension of an existing project?
This is not a brand-new initiative. It is a continuation (Type 2 continuation award) designed to extend momentum and complete work already underway through MDHC, especially activities that could otherwise stall at the end of the original project period.
What is the purpose of providing only one additional year of funding?
The additional year functions as a bridge year to protect and complete established activities that are already in motion, reinforcing partnerships and ensuring proven interventions continue reaching high-need communities in the Mississippi Delta.
What type of funding mechanism is used for this award?
The opportunity is structured as a cooperative agreement, meaning CDC is expected to be actively involved through collaboration and technical assistance rather than simply issuing funds with minimal engagement.
How much funding is available under this opportunity?
The single award totals $3,150,000. The award ceiling and floor are both set at $3,150,000.
Is there any cost sharing or matching requirement?
No. The announcement specifies there is no cost sharing or matching requirement.
How many awards will be made?
This announcement provides for a single award.
Is this a competitive grant open to multiple applicants?
No. This is not a competitive opportunity open to multiple applicants. Eligibility is limited to the original grantee, and no other applications were solicited or reviewed.
Who is eligible to receive this continuation award?
Eligibility is limited to the original grantee: the Mississippi Department of Health / Mississippi Delta Health Collaborative (MDHC).
What is the project period covered by the continuation year?
The continuation budget year covers September 30, 2015 through September 29, 2016.
What was the previously approved project period before this continuation year?
The previously approved project period ran from September 30, 2010 through September 29, 2015.
Where is the program focused geographically?
The work is centered in Mississippi's 18-county Delta Region.
Which populations are prioritized in this program?
The program focuses on priority populations in the Mississippi Delta who experience disproportionate cardiovascular risk and barriers to care.
What health outcomes is the program trying to improve?
The program is designed to reduce heart disease and stroke, and it also addresses related chronic conditions connected to cardiovascular risk.
What is the "ABCS" framework referenced in the announcement?
The ABCS framework is a set of high-impact approaches for preventing heart attacks and strokes: Aspirin therapy when appropriate, Blood pressure control, Cholesterol management, Smoking cessation, and Smoke-free ordinances.
Why does the program include both clinical and community strategies?
The approach intentionally combines clinical care improvements (such as better hypertension management and appropriate medication use) with community-level strategies (such as tobacco cessation supports and smoke-free policies) to reduce risk across the population over time.
What kinds of partners are expected to be involved?
The announcement emphasizes collaboration among the Mississippi Department of Health and its chronic disease programs, local health departments, community health care providers (including Federally Qualified Health Centers), community partners, and CDC as a technical and strategic collaborator.
How does CDC participate in a cooperative agreement like this?
CDC is expected to remain actively involved by providing technical assistance and collaborating with MDHC, rather than acting only as a funder.
What are the main areas of work (recipient activity areas) MDHC is expected to address?
MDHC is expected to complete or address seven major areas: (1) program infrastructure, staffing, management, and operational support; (2) fiscal management; (3) leadership team functions and partnership development/maintenance; (4) clinical interventions to improve prevention and management of cardiovascular risk; (5) community-based educational, policy, and systems interventions; (6) program evaluation and surveillance; and (7) collaboration with other chronic disease programs to integrate efforts and avoid siloed work.
What is meant by "clinical interventions" in this announcement?
Clinical interventions refer to efforts within health care settings to improve how care teams prevent and manage cardiovascular risk, aligned with the ABCS priorities such as blood pressure control and cholesterol management.
What is meant by "community-based educational, policy, and systems interventions"?
These are strategies outside of direct clinical care that shape healthier environments and behaviors, including education, policy efforts such as smoke-free ordinances, and systems-level changes that support prevention.
How will progress and results be measured?
The announcement includes program evaluation and surveillance as a major activity area, indicating MDHC is expected to measure progress, monitor outcomes, and use findings to inform improvements.
Why does the announcement emphasize collaboration with other chronic disease programs?
Because cardiovascular outcomes are closely linked with diabetes, tobacco use, diet, and physical inactivity, the continuation year stresses integrating efforts across chronic disease programs to avoid siloed work.
What is the CFDA number associated with this funding?
The funding falls under CFDA 93.283 (CDC Investigations and Technical Assistance).
How is this funding categorized?
It is categorized as discretionary health funding.
When was this opportunity posted and when were applications due?
The posting date was April 23, 2015. Applications were due June 30, 2015.
When was the opportunity archived?
The archive date was July 30, 2015.
Who is the CDC contact listed for additional information or access issues?
The listed CDC contact is Refilwe Moeti at REM7@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: Office of Postsecondary Education (OPE) Centers of Excellence for Veteran Student Success CFDA Number 84.116G
Previous opportunity: BLM WO, Tread Lightly Education, Training and Restoration Assistance
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DP15 1515
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DP15 1515) also looked into and applied for these:
| Funding Opportunity |
|---|
| Rural Quality Improvement Technical Assistance Cooperative Agreement Apply for HRSA 15 150 Funding Number: HRSA 15 150 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Innovations for Healthy Living Improving Population Health and Eliminating Health Disparities (R43)/(R44) Apply for RFA MD 15 009 Funding Number: RFA MD 15 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Technologies for Improving Population Health and Eliminating Health Disparities (R41/R42) Apply for RFA MD 15 008 Funding Number: RFA MD 15 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| PPHF 2015 REACH Racial and Ethnic Approaches to Community Health (REACH) financed in part by 2015 Prevention and Public Health Funding Apply for CDC RFA DP14 141902PPHF15 Funding Number: CDC RFA DP14 141902PPHF15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Leader Fellowship Program Apply for CDC RFA PS15 1508 Funding Number: CDC RFA PS15 1508 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Dissemination of Evidence Informed Interventions to Improve Health Outcomes along the HIV Care Continuum Implementation Technical Assistance Center Apply for HRSA 15 130 Funding Number: HRSA 15 130 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Dissemination of Evidence Informed Interventions to Improve Health Outcomes along the HIV Care Continuum Dissemination and Evaluation Center Apply for HRSA 15 030 Funding Number: HRSA 15 030 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Analyses of Human Datasets and Biospecimens to Characterize Aging related Phenotypes Relationships to Circulating Polypeptides and Proteins that Reverse or Accelerate Aging Changes (R01) Apply for RFA AG 16 012 Funding Number: RFA AG 16 012 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| T1 Translational Research Novel Interventions for Prevention and Treatment of Age related Conditions (R21) Apply for PAR 15 190 Funding Number: PAR 15 190 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Consortia for Innovative AIDS Research in Nonhuman Primates (UM1) Apply for RFA AI 15 022 Funding Number: RFA AI 15 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Infrastructure Resource Access (X01) Apply for PAR 15 195 Funding Number: PAR 15 195 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| T2 Translational Research Research Leading to New Health Care Practices, Community Programs and Policies Affecting Older Persons (R21) Apply for PAR 15 191 Funding Number: PAR 15 191 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R01) Apply for PAR 15 192 Funding Number: PAR 15 192 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R21) Apply for PAR 15 193 Funding Number: PAR 15 193 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| PPHF 2015 Asian Language Tobacco Quitline financed solely by 2015 Prevention and Public Health Funds Apply for CDC RFA DP15 1503 Funding Number: CDC RFA DP15 1503 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| World Health Organization Addressing Ebola and other Highly Infectious Diseases Internationally Apply for CDC RFA CK15 1505 Funding Number: CDC RFA CK15 1505 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Telehealth Focused Rural Health Research Center Cooperative Agreement Apply for HRSA 15 149 Funding Number: HRSA 15 149 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Small Business Innovation in Clinical Trials Direct to Phase II (U44) Apply for PAR 15 194 Funding Number: PAR 15 194 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Community Sanitation and Nutritional Status in Key Vulnerable Areas in Laos Apply for AID 486 15 000002 Funding Number: AID 486 15 000002 Agency: Thailand USAID Bangkok Category: Health Funding Amount: $5,600,000 |
| Developmental AIDS Research Center on Mental Health and HIV/AIDs (P30) Apply for PAR 15 196 Funding Number: PAR 15 196 Agency: National Institutes of Health Category: Health Funding Amount: $550,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP15 1515", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.